AGP Picks
View all

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on April 9, 2026

Teri Smith-Pickens, Best-Selling Author, Exposes the Psychological Roots of Monophobia and Its Impact on Survival Mode
California Nonprofit Serving Adults with Disabilities Named a USA Today Top Workplace 2026
Perform Medical Releases Comprehensive Perimenopause Care Guide to Address Gaps in Women’s Midlife Health
B&B Optometry Encourages Early Pediatric Eye Exams with 'Back-to-School Vision Starts in Spring' Initiative
California IVF and Surrogacy Reflect Global Shift Toward AI-Driven Fertility Care
Onward Receives $1.9M Access for All Grant to Subsidize WAV Trips Across Four Bay Area Counties
Tarzana Treatment Centers Expands Access to Opioid Treatment with New Mobile NTP Unit
SocialSellinator Named Spring 2026 Top Firm by 50Pros for Excellence in Digital Marketing
IR Centers® and Orange County Urology Associates Partner to Launch Advanced IR Program
Serenity Retirement Specializes in Retirement Income, Medicare and Asset Protection Planning
Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying
FDA Accepts NDA for TLX101-Px (Pixclara®)
Nexcopy Introduces Nexcopy Software Dongle (NSD) with Write-Protected USB Storage
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.

Share this page:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.